Cue Biopharma (CUE) Revenue (2018 - 2025)

Cue Biopharma has disclosed Revenue across 8 years of filings, most recently posting $9.5 million for Q4 2025.

• Revenue for Q4 2025 came in at $9.5 million, up 502.79% year-over-year; the trailing twelve-month figure through Dec 2025 was $15.0 million (up 61.77% YoY), and the FY2025 annual result was $27.5 million, up 195.75% from the prior year.
• Revenue came in at $9.5 million for Q4 2025 at Cue Biopharma, up from $2.1 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $9.5 million in Q4 2025 to a low of $26000.0 in Q2 2022.
• The 5-year median for Revenue is $1.8 million (2023), against an average of $2.3 million.
• Across the five-year window, Revenue sank 99.05% in 2022 and surged 5215.38% in 2023, its largest moves.
• Cue Biopharma's Revenue stood at $8.3 million in 2021, then slumped by 98.17% to $151000.0 in 2022, then surged by 1105.96% to $1.8 million in 2023, then dropped by 13.45% to $1.6 million in 2024, then surged by 502.79% to $9.5 million in 2025.
• The last three Revenue figures came in at $9.5 million (Q4 2025), $2.1 million (Q3 2025), and $3.0 million (Q2 2025), per Business Quant data.